Search results for "Obstructive"

showing 10 items of 609 documents

Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: The BRIGHT study

2014

Summary Introduction QVA149 is a novel, inhaled, once-daily dual bronchodilator containing a fixed-dose combination of the long-acting β 2 -agonist indacaterol and the long-acting muscarinic antagonist glycopyrronium (NVA237), for the treatment of chronic obstructive pulmonary disease (COPD). This study evaluated the effects of QVA149 on exercise tolerance, hyperinflation, lung function and lung volumes versus placebo and tiotropium. Methods Patients with moderate-to-severe COPD were randomized to QVA149 110/50 μg, placebo or tiotropium 18 μg once daily in a blinded, 3-period crossover study for 3 weeks. The primary endpoint was exercise endurance time at Day 21 for QVA149 versus placebo. R…

AdultMalePulmonary and Respiratory Medicinemedicine.drug_classVital CapacityScopolamine DerivativesHyperinflationQuinolonesPlaceboDrug Administration SchedulePulmonary Disease Chronic ObstructiveFunctional residual capacityDouble-Blind MethodForced Expiratory VolumeBronchodilatormedicineClinical endpointHumansLung volumesTiotropium BromideExerciseAgedCOPDCross-Over StudiesExercise Tolerancebusiness.industryChronic obstructive pulmonary diseaseTiotropiumQVA149Middle Agedmedicine.diseaseGlycopyrrolateCrossover studyBronchodilator Agentsrespiratory tract diseasesDrug CombinationsTreatment OutcomeSpirometryAnesthesiaIndansIndacaterolFemaleLung Volume Measurementsbusinessmedicine.drugRespiratory Medicine
researchProduct

Is it possible to predict which patients with mild pneumonias will develop hypoxemia?

2009

SummaryUsually, mortality due to mild community-acquired pneumonias (CAP) (Pneumonia severity index (PSI) classes I–III) is low (<3%), but the appearance of hypoxemia significantly increases mortality. Our aim was to determine the clinical parameters associated with risk factors of developing hypoxemia in subjects with mild CAP (PSI I–III) and the clinical outcomes of the hypoxemic group.We analyzed clinical characteristics and the outcomes of patients with mild CAP and hypoxemia (PaO2/FiO2<300), in a prospective, multicenter cohort study of 1195 patients.Mild pneumonias (PSI I–III) were found in 645 cases (53.9%), of which 217 (33.6%) presented hypoxemia according to a PaO2/FiO2<300. Patie…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAdolescentCommunity-acquired pneumoniamedicine.medical_treatmentPneumonia severity indexSeverity assessmentHypoxemiaHypoxemiaPulmonary Disease Chronic ObstructiveYoung AdultCommunity-acquired pneumoniaHumansMedicineHypoalbuminemiaHypoxiaAgedMechanical ventilationCOPDbusiness.industrySeptic shockPneumoniaMiddle Agedmedicine.diseaserespiratory tract diseasesSurgeryCommunity-Acquired InfectionsRadiographyPneumoniaRisk factorsAnesthesiaFemalemedicine.symptomEpidemiologic MethodsbusinessHypoalbuminemiacirculatory and respiratory physiologyRespiratory Medicine
researchProduct

Airway remodelling assessed by sputum and high resolution computed tomography in asthma and COPD

2004

It is not known whether sputum elastase, metalloproteinase (MMP)-9 and tissue-inhibitor metalloproteinase (TIMP)-1 are related to structural changes of the airways, as assessed by high-resolution computed tomography (HRCT) scan. The relationships between these markers and the magnitude of structural changes of the airways in asthma and chronic obstructive pulmonary disease (COPD) were assessed. Induced sputum and HRCT scan were performed in 30 asthmatics (14 mild and 16 severe) and in 12 patients with COPD. A greater extent of HRCT scan abnormalities was found in COPD than in severe and mild asthmatics. HRCT scan abnormalities correlated with the degree of airway obstruction in COPD and in …

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyPathologyHigh-resolution computed tomographyairway inflammation imagingSettore MED/10 - Malattie Dell'Apparato RespiratorioGastroenterologyStatistics NonparametricPulmonary Disease Chronic ObstructiveInternal medicinemedicineHumansAirway RemodellingAgedAsthmaCOPDTissue Inhibitor of Metalloproteinase-1Pancreatic Elastasemedicine.diagnostic_testbusiness.industryElastaseRespiratory diseaseSputumMiddle Agedrespiratory systemAirway obstructionmedicine.diseaseAsthmaRespiratory Function Testsrespiratory tract diseasesMatrix Metalloproteinase 9SputumFemalemedicine.symptomTomography X-Ray Computedbusiness
researchProduct

Detection of lung cancer in exhaled breath with an electronic nose using support vector machine analysis

2017

Lung cancer is one of the most common malignancies and has a low 5-year survival rate. There are no cheap, simple and widely available screening methods for the early diagnostics of lung cancer. The aim of this study was to determine whether analysis of exhaled breath with an artificial olfactory sensor using support vector analysis can differentiate patients with lung cancer from healthy individuals and patients with other lung diseases, regardless of the stage of lung cancer and the most common comorbidities. Patients with histologically or cytologically verified lung cancer, healthy volunteers and patients with other lung diseases (e.g. chronic obstructive pulmonary disease (COPD), asthm…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyPathologyLung NeoplasmsSupport Vector MachinePulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansElectronic NoseLung cancerSurvival rateAgedNeoplasm StagingAsthmaCOPDLungbusiness.industryCancerMiddle Agedrespiratory systemmedicine.diseaseHealthy Volunteersrespiratory tract diseasesPneumoniamedicine.anatomical_structureBreath Tests030228 respiratory systemExhalationCase-Control Studies030220 oncology & carcinogenesisFemaleSample collectionbusinessJournal of Breath Research
researchProduct

Determinants of physical activity in daily life in candidates for lung transplantation

2012

BACKGROUND: Participation in daily physical activity (PA) has never been objectively assessed in candidates for lung transplantation (LTx). The main research questions were: 1) How active are LTx-candidates in daily life? 2) What are determinants of activity behavior before LTX? METHODS: Ninety-six candidates for LTx (diagnosis of COPD or interstitial lung disease; mean age 55 ± 7 years) underwent measurements of PA, pulmonary function, 6-min walking distance (6MWD), muscle force and health-status (SF-36 scale). RESULTS: Patients were markedly inactive (5% of waking hours walking, 26% standing and 69% sedentary). Backward multiple regression identified 6MWD (expressed as % of predicted valu…

AdultMaleQuality of lifePulmonary and Respiratory Medicinemedicine.medical_specialtyActivities of daily livingCross-sectional studymedicine.medical_treatmentPhysical activityMEDLINEWalkingMotor ActivityPulmonary Disease Chronic ObstructiveQuality of life (healthcare)Forced Expiratory VolumeActivities of Daily LivingmedicineExercise capacityHumansLung transplantationbusiness.industryPhysical activityMuscle strengthMiddle Agedrespiratory systemExercise capacitymedicine.diseaseRespiratory MusclesCross-Sectional StudiesLung transplantationMood disordersPreoperative PeriodRespiratory MechanicsPhysical therapyMood disordersFemaleSeasonsHuman medicineLung Diseases InterstitialbusinessRespiratory Medicine
researchProduct

Obstructive sleep apnoea syndrome (OSAS): effects on the vestibular system

2010

SUMMARY Aim of the present study was to evaluate the effects of obstructive sleep apnoea syndrome (OSAS) on the peripheral and central vestibular system, by means of a case series prospective study at the University referral centre of Otolaryngology Head and Neck Surgery; 45 consecutive patients suffering from OSAS were compared with a control group of 30 volunteer subjects selected from among the department employees. Severity of the disease was evaluated by means of cardio-respiratory function monitoring during sleep; the apnoea-hypopnoea index was calculated. Both groups underwent: 1) head and neck examination; 2) fibre-optic examination; 3) pure tone audiometry; 4) evaluation of eye mov…

AdultMaleSleep Apnea ObstructiveOSASMiddle AgedDizzinessVestibologyImbalanceYoung AdultVestibular DiseasesVertigoHumansDisequilibriumFemaleProspective StudiesActa Otorhinolaryngologica Italica
researchProduct

Analysis of the correlations between oxidative stress, gelatinases and their tissue inhibitors in the human subjects with obstructive sleep apnea syn…

2015

Obstructive sleep apnea syndrome (OSAS) is commonly associated with endothelial dysfunction, atherosclerosis and cardiovascular disorders. On the basis of this observation, our aim was to examine the oxidative status and the matrix metalloproteases (MMP) profile in a group of subjects with OSAS. We enrolled 48 subjects with OSAS defined after a 1-night cardiorespiratory sleep study, who were subsequently subdivided in two subgroups according to the severity of OSAS (low grade = L-OSAS; high grade= H-OSAS). We measured the parameters of oxidative stress, such as lipid peroxidation, protein oxidation, total antioxidant status (TAS), nitric oxide metabolites (NOx), and the plasma concentration…

AdultMaleSleep Apnea ObstructiveTissue Inhibitor of Metalloproteinase-2Tissue Inhibitor of Metalloproteinase-1Settore MED/09 - Medicina InternaMiddle AgedNitric OxideThiobarbituric Acid Reactive SubstancesOxidative StressMatrix Metalloproteinase 9Thiobarbituric Acid Reactive SubstanceHumansMatrix Metalloproteinase 2FemaleSettore MED/36 - Diagnostica Per Immagini E RadioterapiaAdult; Aged; Female; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Nitric Oxide; Sleep Apnea Obstructive; Thiobarbituric Acid Reactive Substances; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Oxidative StressAgedHuman
researchProduct

Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany

2012

Thomas Glaab1,2, Claus Vogelmeier3, Andreas Hellmann4, Roland Buhl11Department of Respiratory Diseases III, Medical Center of the Johannes Gutenberg-University, Mainz, 2Medical Affairs Germany, Respiratory Medicine, Boehringer Ingelheim Pharma GmbH and Co, KG, Ingelheim, 3Department of Respiratory Diseases, University Hospitals of Giessen and Marburg, Marburg, 4Federal Association of Pneumologists, Augsburg, GermanyBackground: Little is known about the role of guidelines for the practical management of chronic obstructive pulmonary disease (COPD) by office-based pulmonary specialists. The aim of this study was to assess their outpatient management in relation to current guideline recommenda…

AdultMaleSpirometryHealth Knowledge Attitudes Practicemedicine.medical_specialtyChronic bronchitisAttitude of Health Personneldiagnosismedicine.medical_treatmentInternational Journal of Chronic Obstructive Pulmonary DiseasePulmonary Disease Chronic ObstructivePatient Education as TopicAmbulatory careRisk FactorsGermanySurveys and QuestionnairesHealth careAmbulatory CaremedicineHumanssurveyPulmonary rehabilitationGOLDPractice Patterns Physicians'Referral and ConsultationOriginal ResearchtherapyCOPDEvidence-Based Medicinemedicine.diagnostic_testbusiness.industryGeneral MedicineGuidelineMiddle Agedmedicine.diseasepulmonary rehabilitationclinical outcomesObstructive lung diseaseRespiratory Function TestsBenchmarkingCross-Sectional StudiesHealth Care SurveysFamily medicinePractice Guidelines as TopicFemaleGuideline AdherencebusinessInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Blood pressure changes after automatic and fixed CPAP in obstructive sleep apnea. Relationship with nocturnal sympathetic activity.

2011

Treatment of obstructive sleep apnea (OSA) by continuous positive airway pressure (CPAP) usually causes a reduction in blood pressure (BP), but several factors may interfere with its effects. In addition, although a high sympathetic activity is considered a major contributor to increased BP in OSA, a relationship between changes in BP and in sympathetic nervous system activity after OSA treatment is uncertain. This study was undertaken to assess if, in OSA subjects under no pharmacologic treatment, treatment by CPAP applied at variable levels by an automatic device (APAP) may be followed by a BP reduction, and if that treatment is associated with parallel changes in BP and catecholamine exc…

AdultMaleSympathetic nervous systemSympathetic Nervous SystemAmbulatory blood pressurePhysiologymedicine.medical_treatmentambulatory blood pressure monitoring catecholaminesBlood PressureSettore MED/10 - Malattie Dell'Apparato RespiratorioNorepinephrineCatecholaminesInternal MedicinemedicineHumansContinuous positive airway pressureWakefulnessSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industrySleep apneaGeneral MedicineBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseCircadian RhythmNormetanephrinenervous system diseasesrespiratory tract diseasesObstructive sleep apneamedicine.anatomical_structureBlood pressureAnesthesiaAmbulatoryCatecholamineSleepbusinessmedicine.drug
researchProduct

Relaxin in Obstructive Sleep Apnea: Relationship with Blood Pressure and Inflammatory Mediators

2015

&lt;b&gt;&lt;i&gt;Background:&lt;/i&gt;&lt;/b&gt; Obstructive sleep apnea (OSA) is associated with nocturnal intermittent hypoxia, which may be responsible for increased circulating levels of vascular endothelial growth factor (VEGF) and inflammatory mediators, such as metalloproteinases (MMPs), and which contributes to the pathogenesis of systemic hypertension. Why some OSA patients remain normotensive is poorly understood. Relaxin-2, a pregnancy hormone, may sometimes circulate in men and could increase in hypoxic conditions. It exerts a vasodilatory activity and can modulate the release of molecules, such as MMPs and VEGF. &lt;b&gt;&lt;i&gt;Objectives:&lt;/i&gt;&lt;/b&gt; The objective o…

AdultMaleVascular Endothelial Growth Factor APulmonary and Respiratory Medicinemedicine.medical_specialtyAmbulatory blood pressurePolysomnographyBlood PressurePolysomnographySettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRelaxin · Obstructive sleep apnea · Metalloproteinase · Vascular endothelial growth factorInterquartile rangeInternal medicineRespiratory disturbance indexmedicineHumansHypoxiaInflammationSleep Apnea ObstructiveTissue Inhibitor of Metalloproteinase-2Tissue Inhibitor of Metalloproteinase-1medicine.diagnostic_testbusiness.industryRelaxinSleep apneaTissue Inhibitor of MetalloproteinasesIntermittent hypoxiaMiddle Agedmedicine.diseaseMatrix MetalloproteinasesObstructive sleep apneaEndocrinologyBlood pressureMatrix Metalloproteinase 9030228 respiratory systemHypertensionMatrix Metalloproteinase 2Inflammation MediatorsbusinessRespiration
researchProduct